- Filed
- Feb 6, 2019 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2019 · Dec 31, 2018 | 1.86B sh |
| Shares Diluted | Q2 2019 · Dec 31, 2018 | 1.86B sh |
| Shares Diluted | Q2 2019 · Dec 31, 2017 | 1.86B sh |
| Shares Diluted | Q2 2019 · Dec 31, 2017 | 1.85B sh |
| Capex | Q2 2019 · Dec 31, 2018 | $219M |
| Capex | Q2 2019 · Dec 31, 2017 | $238M |
| Long Term Debt | Q2 2019 · Dec 31, 2018 | $18.32B |
| Long Term Debt | Q2 2019 · Jun 30, 2018 | $18.47B |
| Cash And Equivalents | Q2 2019 · Dec 31, 2018 | $21.28B |
| Cash And Equivalents | Q2 2019 · Jun 30, 2018 | $7.62B |
| Cash And Equivalents | Q2 2019 · Dec 31, 2017 | $5.81B |
| Cash And Equivalents | Q2 2019 · Jun 30, 2017 | $6.16B |
| Stockholders Equity | Q2 2019 · Dec 31, 2018 | $32.01B |
| Stockholders Equity | Q2 2019 · Jun 30, 2018 | $19.56B |
| Current Liabilities | Q2 2019 · Dec 31, 2018 | $7.94B |
| Current Liabilities | Q2 2019 · Jun 30, 2018 | $8.24B |
| Current Assets | Q2 2019 · Dec 31, 2018 | $34.02B |
| Current Assets | Q2 2019 · Jun 30, 2018 | $19.33B |
| Total Assets | Q2 2019 · Dec 31, 2018 | $65.89B |
| Total Assets | Q2 2019 · Jun 30, 2018 | $53.83B |
| Eps Diluted | Q2 2019 · Dec 31, 2018 | $5.80 |
| Eps Diluted | Q2 2019 · Dec 31, 2018 | $6.49 |
| Eps Diluted | Q2 2019 · Dec 31, 2017 | $0.99 |
| Eps Diluted | Q2 2019 · Dec 31, 2017 | $1.45 |
| Eps Basic | Q2 2019 · Dec 31, 2018 | $5.83 |
| Eps Basic | Q2 2019 · Dec 31, 2018 | $6.52 |
| Eps Basic | Q2 2019 · Dec 31, 2017 | $0.99 |
| Eps Basic | Q2 2019 · Dec 31, 2017 | $1.45 |
| Sga Expense | Q2 2019 · Dec 31, 2018 | $939M |
| Sga Expense | Q2 2019 · Dec 31, 2018 | $1.83B |
| Sga Expense | Q2 2019 · Dec 31, 2017 | $864M |
| Sga Expense | Q2 2019 · Dec 31, 2017 | $1.71B |
| Revenue | Q2 2019 · Dec 31, 2018 | $8.5B |
| Revenue | Q2 2019 · Dec 31, 2018 | $15.68B |
| Revenue | Q2 2019 · Dec 31, 2017 | $8.04B |
| Revenue | Q2 2019 · Dec 31, 2017 | $15.04B |
| Total Liabilities | Q2 2019 · Jun 30, 2018 | $32.27B |